Product Details for NDA 008453
ANECTINE (SUCCINYLCHOLINE CHLORIDE)
20MG/ML
Marketing Status: Prescription
50MG/ML
Marketing Status: Discontinued
500MG/VIAL
Marketing Status: Discontinued
1GM/VIAL
Marketing Status: Discontinued
20MG/ML
Marketing Status: Prescription
Active Ingredient: SUCCINYLCHOLINE CHLORIDE
Proprietary Name: ANECTINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N008453
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Prescription
Patent and Exclusivity Information
ANECTINE (SUCCINYLCHOLINE CHLORIDE)
Proprietary Name: ANECTINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N008453
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Prescription
Patent and Exclusivity Information
50MG/ML
Marketing Status: Discontinued
Active Ingredient: SUCCINYLCHOLINE CHLORIDE
Proprietary Name: ANECTINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 50MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N008453
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Discontinued
Patent and Exclusivity Information
ANECTINE (SUCCINYLCHOLINE CHLORIDE)
Proprietary Name: ANECTINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 50MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N008453
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Discontinued
Patent and Exclusivity Information
500MG/VIAL
Marketing Status: Discontinued
Active Ingredient: SUCCINYLCHOLINE CHLORIDE
Proprietary Name: ANECTINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 500MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N008453
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Discontinued
Patent and Exclusivity Information
ANECTINE (SUCCINYLCHOLINE CHLORIDE)
Proprietary Name: ANECTINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 500MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N008453
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Discontinued
Patent and Exclusivity Information
1GM/VIAL
Marketing Status: Discontinued
Active Ingredient: SUCCINYLCHOLINE CHLORIDE
Proprietary Name: ANECTINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1GM/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N008453
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: ANECTINE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1GM/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N008453
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Discontinued
Patent and Exclusivity Information